WaveMan · Form 4
Silverman Joshua insider trades
> Search tickers & screens ⌘K
LIVE

Silverman Joshua insider trades

Silverman Joshua has filed 43 Form 4s with the SEC that we hold, for TAO Synergies Inc. (TAOX) (Executive Chairman, Director), Petros Pharmaceuticals, Inc. (PTPI) (Director), Fabric.AI, Inc. (FABC) (Chief Executive Officer, Director) and Q/C Technologies, INC. (QCLS) (Executive Chairman, Director), among 6 companies in all. Across all of them we count 6 purchases worth $183.6K and 6 sales worth $58.4K reported on Form 4. In the last 12 months: 3 purchases ($80.3K) and 0 sales ($0). The largest single trade was a purchase of 6,734 shares of Q/C Technologies, INC. worth $42.4K, dated 2021-11-24. The first filing on our record is dated 2021-07-15 and the latest 2026-10-02.

TAO Synergies Inc. (TAOX)

Executive Chairman, Director · 12 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2022-12-16S, sale reported on Form 419,012$22.2K2022-12-20

Petros Pharmaceuticals, Inc. (PTPI)

Director · 9 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Fabric.AI, Inc. (FABC)

Chief Executive Officer, Director · 8 filings · 5 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-05-11S, sale reported on Form 412,855$10.5K2022-11-03
2022-11-01S, sale reported on Form 47,171$4.2K2022-11-03
2023-01-30S, sale reported on Form 47,171$5.1K2023-02-03
2023-05-03S, sale reported on Form 411,927$5.8K2023-05-05
2023-08-01S, sale reported on Form 412,740$10.4K2023-08-03

Q/C Technologies, INC. (QCLS)

Executive Chairman, Director · 8 filings · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-11-24P, purchase reported on Form 43,266$23.2K2021-11-29
2021-11-24P, purchase reported on Form 46,734$42.4K2021-11-29
2021-11-26P, purchase reported on Form 45,000$37.8K2021-11-29

Femasys INC (FEMY)

Director · 3 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

PharmaCyte Biotech, Inc. (PMCB)

CEO and President, Director · 3 filings · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2026-01-05P, purchase reported on Form 430,000$23.4K2026-01-07
2026-01-06P, purchase reported on Form 430,000$23.7K2026-01-07
2026-01-07P, purchase reported on Form 440,000$33.2K2026-01-07
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1524858) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms